These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34166410)

  • 21. Performance of two rapid antigen tests against SARS-CoV-2 in neighborhoods of socioeconomic vulnerability from a middle-income country.
    Zeballos D; Magno L; Aranha Rossi T; Soares F; Pinto Junior JA; Ferreira O; Carvalho Dos Santos C; Reis JN; Torres TS; Veloso VG; Dourado I
    PLoS One; 2024; 19(6):e0298579. PubMed ID: 38905178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting.
    Kim AE; Bennett JC; Luiten K; O'Hanlon JA; Wolf CR; Magedson A; Han PD; Acker Z; Regelbrugge L; McCaffrey KM; Stone J; Reinhart D; Capodanno BJ; Morse SS; Bedford T; Englund JA; Boeckh M; Starita LM; Uyeki TM; Carone M; Weil A; Chu HY
    J Infect Dis; 2024 Aug; 230(2):363-373. PubMed ID: 38531685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.
    Jakobsen KK; Jensen JS; Todsen T; Tolsgaard MG; Kirkby N; Lippert F; Vangsted AM; Martel CJ; Klokker M; von Buchwald C
    Dan Med J; 2021 Jun; 68(7):. PubMed ID: 34169830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
    Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples.
    Nóra M; Déri D; Veres DS; Kis Z; Barcsay E; Pályi B
    PLoS One; 2022; 17(2):e0262399. PubMed ID: 35157700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use.
    Krüger LJ; Gaeddert M; Tobian F; Lainati F; Gottschalk C; Klein JAF; Schnitzler P; Kräusslich HG; Nikolai O; Lindner AK; Mockenhaupt FP; Seybold J; Corman VM; Drosten C; Pollock NR; Knorr B; Welker A; de Vos M; Sacks JA; Denkinger CM;
    PLoS One; 2021; 16(5):e0247918. PubMed ID: 34043631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation.
    Irungu JK; Munyua P; Ochieng C; Juma B; Amoth P; Kuria F; Kiiru J; Makayotto L; Abade A; Bulterys M; Hunsperger E; Emukule GO; Onyango C; Samandari T; Barr BAT; Akelo V; Weyenga H; Munywoki PK; Bigogo G; Otieno NA; Kisivuli JA; Ochieng E; Nyaga R; Hull N; Herman-Roloff A; Aman R
    PLoS One; 2023; 18(1):e0277657. PubMed ID: 36696882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department.
    Carbonell-Sahuquillo S; Lázaro-Carreño MI; Camacho J; Barrés-Fernández A; Albert E; Torres I; Bretón-Martínez JR; Martínez-Costa C; Navarro D
    J Med Virol; 2021 Dec; 93(12):6803-6807. PubMed ID: 34289136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study.
    Meiners L; Horn J; Jones TC; Mühlemann B; Schmidt ML; Walper F; Menzel P; Schwarzer R; Rose R; Krumbholz A; Corman VM; Seybold J; Drosten C
    Lancet Microbe; 2024 Jun; 5(6):e538-e546. PubMed ID: 38759669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
    Veyrenche N; Bolloré K; Pisoni A; Bedin AS; Mondain AM; Ducos J; Segondy M; Montes B; Pastor P; Morquin D; Makinson A; Le Moing V; Van de Perre P; Foulongne V; Tuaillon E
    J Med Virol; 2021 May; 93(5):3069-3076. PubMed ID: 33554363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022.
    Wagenhäuser I; Knies K; Hofmann D; Rauschenberger V; Eisenmann M; Reusch J; Gabel A; Flemming S; Andres O; Petri N; Topp MS; Papsdorf M; McDonogh M; Verma-Führing R; Scherzad A; Zeller D; Böhm H; Gesierich A; Seitz AK; Kiderlen M; Gawlik M; Taurines R; Wurmb T; Ernestus RI; Forster J; Weismann D; Weißbrich B; Dölken L; Liese J; Kaderali L; Kurzai O; Vogel U; Krone M
    Clin Microbiol Infect; 2023 Feb; 29(2):225-232. PubMed ID: 36028089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France.
    Fitoussi F; Tonen-Wolyec S; Awaida N; Dupont R; Bélec L
    Infection; 2022 Jun; 50(3):625-633. PubMed ID: 34689310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily SARS-CoV-2 Nasal Antigen Tests Miss Infected and Presumably Infectious People Due to Viral Load Differences among Specimen Types.
    Viloria Winnett A; Akana R; Shelby N; Davich H; Caldera S; Yamada T; Reyna JRB; Romano AE; Carter AM; Kim MK; Thomson M; Tognazzini C; Feaster M; Goh YY; Chew YC; Ismagilov RF
    Microbiol Spectr; 2023 Aug; 11(4):e0129523. PubMed ID: 37314333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Detection Testing in Symptomatic and Asymptomatic Children in the Clinical Setting.
    L'Huillier AG; Lacour M; Sadiku D; Gadiri MA; De Siebenthal L; Schibler M; Eckerle I; Pinösch S; Kaiser L; Gervaix A; Glangetas A; Galetto-Lacour A; Lacroix L
    J Clin Microbiol; 2021 Aug; 59(9):e0099121. PubMed ID: 34190574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda.
    Bwogi J; Lutalo T; Tushabe P; Bukenya H; Eliku JP; Ssewanyana I; Nabadda S; Nsereko C; Cotten M; Downing R; Lutwama J; Kaleebu P; ;
    PLoS One; 2022; 17(5):e0265334. PubMed ID: 35536792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy.
    Saeed U; Uppal SR; Piracha ZZ; Rasheed A; Aftab Z; Zaheer H; Uppal R
    Virol J; 2021 Feb; 18(1):34. PubMed ID: 33581714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis.
    Soleimani R; Deckers C; Huang TD; Bogaerts P; Evrard S; Wallemme I; Habib B; Rouzé P; Denis O
    J Med Virol; 2021 Sep; 93(9):5655-5659. PubMed ID: 34009649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests.
    Goodall BL; LeBlanc JJ; Hatchette TF; Barrett L; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0021722. PubMed ID: 35762772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
    LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.